Onlymyhealth on MSN15h
Sickle Cell Disease Surges In Rajasthan’s Tribal Districts, Over 10,000 Affected: Report
Over 10000 people in Rajasthan’s tribal districts are affected by Sickle Cell Disease with nearly 3000 testing positive Learn ...
Agios Pharmaceuticals reports results from Phase 3 ACTIVATE-Kids study
Agios Pharmaceuticals (AGIO) announced that the ACTIVATE-Kids Phase 3 study of mitapivat in children aged 1 to less than18 years with PK ...
Daily Excelsior22h
A day to address Anemia
Dr Ravinder K Gupta, Dr Akhilpreet Kaur Anemia is a serious global public health problem that particularly affects young ...
Agios’ Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint
ACTIVATE-Kids is the First Study to Demonstrate Efficacy of an Oral Therapy for Children with PK Deficiency Who Are Not Regularly Transfused –– ...
St. Louis American2h
Wash U student study explore sickle cell impact on thinking
In addition to the prolonged pain and suffering endured by sickle cell patients, a Washington University School of Medicine ...
Earnings call transcript: Agios Pharm Q4 2024 beats EPS forecast, stock rises
Agios Pharmaceuticals reported its fourth-quarter 2024 earnings, surpassing analysts' expectations with an earnings per share (EPS) of -$1.44 compared to the forecast of -$1.68. The company also ...